Weekly Analysts’ Ratings Changes for Synopsys (SNPS)
by Tristan Rich · The Markets DailySeveral analysts have recently updated their ratings and price targets for Synopsys (NASDAQ: SNPS):
- 9/11/2026 – Synopsys was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
- 9/10/2026 – Synopsys was upgraded by Wells Fargo & Company from “equal weight” to “overweight”. They now have a $475.00 price target on the stock, up from $450.00.
- 8/27/2026 – Synopsys was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
- 8/27/2026 – Synopsys was given a new $570.00 price target by UBS Group AG.
- 8/27/2026 – Synopsys had its price target lowered by Mizuho from $600.00 to $550.00. They now have an “outperform” rating on the stock.
- 8/27/2026 – Synopsys was upgraded by Robert W. Baird from “neutral” to “outperform”. They now have a $560.00 price target on the stock, up from $558.00.
- 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co.. They now have a $570.00 price target on the stock.
- 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $580.00 price target on the stock.
- 8/25/2026 – Synopsys had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $575.00 price target on the stock.
- 8/21/2026 – Synopsys was downgraded by Zacks Research from “strong-buy” to “hold”.
- 8/19/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co..
- 8/19/2026 – Synopsys had its price target lowered by Morgan Stanley from $525.00 to $500.00. They now have an “equal weight” rating on the stock.
- 8/19/2026 – Synopsys had its “overweight” rating reaffirmed by KeyCorp.
- 8/11/2026 – Synopsys had its price target lowered by Wells Fargo & Company from $535.00 to $450.00. They now have an “equal weight” rating on the stock.
Insider Activity at Synopsys
In other news, insider Aart de Geus sold 25,000 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the transaction, the insider directly owned 120,421 shares in the company, valued at $53,197,180.96. This represents a 17.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 74,641 shares of company stock worth $32,518,171. Corporate insiders own 0.56% of the company’s stock.
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and related services. Its products help semiconductor and electronics companies design, verify, test and manufacture integrated circuits and complex electronic systems.
The company’s EDA portfolio includes tools for digital and analog design, simulation, verification, physical implementation, signoff and manufacturing preparation. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, embedded memories and security-related components, which customers can incorporate into system-on-chip designs.
Synopsys additionally offers software integrity and application security solutions that help organizations identify and manage vulnerabilities and risks in the software development lifecycle.